Larry W Tsai

Title: Innovations of Larry W Tsai in Lung Volume Reduction Therapy

Introduction

Larry W Tsai is an accomplished inventor based in Boston, MA (US). He holds a total of 7 patents that focus on advancements in medical therapies, particularly in the field of lung volume reduction.

Latest Patents

One of his latest patents involves lung volume reduction therapy using crosslinked non-natural polymers. This invention includes a hydrogel comprising a non-natural polymer with a plurality of pendant nucleophilic groups and a crosslinker with at least two pendant electrophilic groups. Another aspect of this invention features a hydrogel with a non-natural polymer containing a plurality of pendant electrophilic groups and a crosslinker with at least two pendant nucleophilic groups. Additionally, the invention outlines a method for reducing lung volume in a patient by administering a hydrogel composition as described. The hydrogels developed may also be utilized for pleurodesis, sealing brochopleural fistulas, sealing air leaks in the lung, achieving hemostasis, and tissue sealing for blood vessels and internal organs. These compositions and methods are particularly intended for treating patients with emphysema.

Career Highlights

Throughout his career, Larry W Tsai has worked with notable companies, including Aeris Therapeutics, Inc. His contributions to the field of medical innovation have significantly impacted lung therapy practices.

Collaborations

Larry has collaborated with esteemed colleagues such as Edward P Ingenito and Alexander Schwarz, further enhancing the development of his innovative therapies.

Conclusion

Larry W Tsai's work in lung volume reduction therapy showcases his dedication to improving medical treatments for patients with emphysema. His innovative patents and collaborations highlight the importance of advancements in healthcare technology.